[1]
Kerget, B. et al. 2024. Comparison of methotrexate and methylprednisolone as addition to antifibrotic therapy in progressive pulmonary fibrosis due to COVID-19. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 41, 4 (Dec. 2024), e2024054. DOI:https://doi.org/10.36141/svdld.v41i4.15614.